期刊文献+

血浆可溶性白细胞介素6受体β糖蛋白链检测试剂盒的研制 被引量:7

Creation of sgp130 detecting Kit
原文传递
导出
摘要 目的研制血浆或细胞培养上清可溶性白细胞介素6受体糖蛋白130(sgp130)的酶联免疫吸附测定(ELISA)检测国产试剂盒,为sgp130ELISA的检测提供便利条件。方法单克隆抗体(单抗)经生物素标记后,采用双抗体夹心法,显色系统选用辣根过氧化物酶(HRP)亲和素/邻苯二胺(OPD)溶液,对7株小鼠抗人sgp130单抗进行不同的组合配对,选择最佳配对用以检测sgp130。结果以单抗BT12包被,二抗为生物素标记的BT2。这一配对可用于血浆或细胞培养上清sgp130水平的检测,检测灵敏度为3.12ng/ml。结论利用识别sgp130不同表位的2株单抗可建立其ELISA检测方法。本法灵敏度高,方法简便,适合临床使用。 Objective To establish an ELISA method for detecting levels of soluble gp130 (sgp130) in plasma (or cell culture supernatant) and create a sgp130 ELISA kit.Methods Labeled with biotin, the best couple of MAbs detecting sgp130 can be chosen among 7 MAbs (anti sgp130) using sandwich method. The optical system is HRP biotin and OPD solution.Results BT12 (MAb for coating) and biotin labeled BT2 *(the second MAb) were the best couple to detect sgp130 levels in plasma (or cell culture supernatant). The sensitivity of this method were about 3.12 ng/ml.Conclusion Using 2 MAbs which recognize the deferent epitopes of sgp130, we can establish he ELISA method for detecting sgp130. Because of its high sensitivity and easy operation, this method can be used in clinical laboratory.
出处 《中华医学检验杂志》 CSCD 1998年第6期352-354,共3页
基金 国家自然科学基金
关键词 试剂盒 受体 白细胞介素6 β糖蛋白链 ELISA Membrane glycoproteins Receptors, interleukin Antibodies, monoclonal Reagent kits, diagnostic
  • 相关文献

同被引文献22

  • 1段云波.峰值骨量、骨丢失和骨折危险度评价[J].国外医学(老年医学分册),1994,15(5):214-218. 被引量:10
  • 2刘蓓岭,王江方,张学光.高度灵敏特异的检测白细胞介素11的生物学方法[J].中华血液学杂志,1996,17(12):654-655. 被引量:1
  • 3Tamura T, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6[J]. Proc Natl Acad Sci USA, 1993, 99:11924~11928
  • 4Lin SC, Yamate T, Taguchi Y, et al. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow[J]. The J of Clin Inve, 1997, 100(8):1980~1990
  • 5Gaillard J, Pugniere M, Tresca J, et al. Interleukin-6 receptor signaling.Ⅱ. Bio-availability of interleukin-6 in serum[J]. Eur Cytokine Netw, 1999,10(3):337~344
  • 6Ershler WB, Keller ET. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty source[J]. Annu Ren Med, 2000, 51(1):245~27
  • 7Papanicolaou DA, Wilder RL, Manolagas SC, et al. The pathophysiologic roles of interleukin-6 in human disease[J]. Annals of Internal Medicine, 1998,128(2):127~137
  • 8Peters M, Meyer zum Buschenfelde KH, Rose-John S. The function of the soluble IL-6 receptor in vivo[J]. Immunol Lett, 1996, 54(2-3):177~184
  • 9Kimble RB, Matayoshi AB. Stimmultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period.Endocrinology,1995,136:3054-3061.
  • 10Manolagas SC,Bellido T,Jilka RT.New insights into the cellular,biochemical,and molecular basis of postmenopausal and senile osteoporosis:roles of interleukin-6 and gp130.Int J Immunopharmac,1995,17:109-116.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部